Effects of enobosarm on muscle wasting and physical function in patients with cancer: A double-blind, randomised controlled phase 2 trial

The Lancet Oncology

Volumn 14, Issue 4, 2013, Pages 335-345

  Dobs, Adrian S ^a   Boccia, Ralph V ^b   Croot, Christopher C ^c   Gabrail, Nashat Y ^d   Dalton, James T ^e   Hancock, Michael L ^e   Johnston, Mary A ^e   Steiner, Mitchell S ^e  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Center for Cancer and Blood Disorders   (United States)

^c North Mississippi Hematology and Oncology Associates   (United States)

^d Gabrail Cancer Center   (United States)

^e GTx   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENT; ENOBOSARM; PLACEBO;

ADULT; ANEMIA; ARGENTINA; ARTICLE; ASTHENIA; BRAIN STEM INFARCTION; CANCER GROWTH; CANCER PATIENT; CELLULITIS; CONSTIPATION; CONTROLLED STUDY; COUGHING; DEPRESSION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MULTICENTER STUDY; MUSCLE ATROPHY; NAUSEA; PHASE 2 CLINICAL TRIAL; PHYSICAL PERFORMANCE; PNEUMONIA; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; UNITED STATES;

AMIDES; ARGENTINA; BODY MASS INDEX; CACHEXIA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MUSCLES; NEOPLASMS; UNITED STATES; WEIGHT LOSS;

EID: 84875804562     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(13)70055-X     Document Type: Article

References (32)

1. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011, 12:489-495.
2. Morley JE, Thomas DR, Wilson MM Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 2006, 83:735-743.
3. Fox KM, Brooks JM, Gandra SR, Markus R, Chiou CF Estimation of cachexia among cancer patients based on four definitions. J Oncol 2009, 2009:693458.
4. Baracos VE, Reiman T, Mourtzakis M, Gioulbasanis I, Antoun S Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 2010, 91:S1133-S1137.
5. Basaria S, Wahlstrom JT, Dobs AS Clinical review 138: anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab 2001, 86:5108-5117.
6. Prado CMM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008, 9:629-635.
7. Narayanan R, Coss CC, Yepuru M, Kearbey JD, Miller DD, Dalton JT Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways. Mol Endocrinol 2008, 22:2448-2465.
8. Dalton JT, Barnette KG, Bohl CE, et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle 2011, 2:153-161.
9. Moyle GJ, Daar ES, Gertner JM, et al. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2004, 35:367-375.
10. Bean JF, Kiely DK, LaRose S, Alian J, Frontera WR Is stair climb power a clinically relevant measure of leg power impairments in at-risk older adults?. Arch Phys Med Rehabil 2007, 88:604-609.
11. LeBrasseur NK, Bhasin S, Miciek R, Storer TW Tests of muscle strength and physical function: reliability and discrimination of performance in younger and older men and older men with mobility limitations. J Am Geriatr Soc 2008, 56:2118-2123.
12. Bhasin S, Calof OM, Storer TW, et al. Drug insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging. Nat Clin Pract Endocrinol Metab 2006, 2:146-159.
13. Schroeder ET, He J, Yarasheski KE, et al. Value of measuring muscle performance to assess changes in lean mass with testosterone and growth hormone supplementation. Eur J Appl Physiol 2012, 112:1123-1131.
14. de Oliveira DG, Nunes PM, Aruin AS, Dos Santos MJ Grip force control in individuals with hand osteoarthritis. J Hand Ther 2011, 24:345-354.
15. Bagis S, Sahin G, Yapici Y, Cimen OB, Erdogan C The effect of hand osteoarthritis on grip and pinch strength and hand function in postmenopausal women. Clin Rheumatol 2003, 22:420-424.
16. Janssen WG, Bussmann HB, Stam HJ Determinants of the sit-to-stand movement: a review. Phys Ther 2002, 82:866-879.
17. Mazzà C, Benvenuti F, Bimbi C, Stanhope SJ Association between subject functional status, seat height, and movement strategy in sit-to-stand performance. J Am Geriatr Soc 2004, 52:1750-1754.
18. Klein S, Kinney J, Jeejeebhoy K, et al. Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 1997, 66:683-706.
19. Grimble RF Nutritional therapy for cancer cachexia. Gut 2003, 52:1391-1392.
20. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010, 363:733-742.
21. Bohl CE, Miller DD, Chen J, Bell CE, Dalton JT Structural basis for accommodation of nonsteroidal ligands in the androgen receptor. J Biol Chem 2005, 280:37747-37754.
22. Moncada E Familial study of hirsutism. J Clin Endocrinol Metab 1970, 31:556-564.
23. Ferriman D, Gallwey JD Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961, 21:1440-1447.
24. Wilcock A Anorexia: A taste of things to come?. Palliat Med 2006, 20:43-45.
25. Lieffers J, Bathe O, Fassbender K, Winget M, Baracos V Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012, 107:931-936.
26. Kortebein P, Ferrando A, Lombeida J, Wolfe R, Evans WJ Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA 2007, 297:1772-1774.
27. Studenski S, Perera S, Wallace D, et al. Physical performance measures in the clinical setting. J Am Geriatric Soc 2003, 51:314-322.
28. Kwon S, Perera S, Pahor M, et al. What is meaningful change in physical performance? Findings from a clinical trial in older adults (the LIFE-P study). J Nutr Health Aging 2009, 13:538-544.
29. Perera S, Mody SH, Woodman RC, Studenski SA Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 2006, 54:746-749.
30. Bruera E ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 1997, 315:1219-1222.
31. Hazem A, Elamin MB, Bancos I, et al. Body composition and quality of life in older adults treated with GH therapy: a systemic review and meta-analysis. Eur J Endocrinol 2012, 166:13-20.
32. Dhillon S Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy. Drugs 2011, 71:1071-1091.